Key Metrics of Harvard Bioscience
Revenue$112M▼ 1.0% YoYFY 2023
Operating income$1.9M▲ 127.3% YoY
Net profit−$3.4M▲ 64.1% YoY
Shareholders' equity$73.1M
Market cap$38.0MHBIO · $8.34
Competitors10identified
About Harvard Bioscience
Sectors
Company details
- Website
- harvardbioscience.com
- Founded
- 2000
- Listed
- Nasdaq: HBIO (since 2000)
Operational Areas of Harvard Bioscience
Pharmaceuticals & Healthcare›Formulations & Contract Manufacturing
Company summary
Legal nameHarvard Bioscience Inc.
TickerHBIO
ExchangeNasdaq
CountryUnited States
SEC CIK0001123494
Listed since2000
IndustryBiotechnology: Laboratory Analytical Instruments
SectorPharmaceuticals & Healthcare · Formulations & Contract Manufacturing
Websitehttp://www.harvardbioscience.com
US market & SEC filings
HBIO · Nasdaq · SEC CIK 0001123494
Last price · 25 Oct 2026
$8.34
−1.77%
Market cap$38.0M
P/E—On FY 2023 diluted EPS
Volume4,438
SectorIndustrialsBiotechnology: Laboratory Analytical Instruments
Country · IPOUnited StatesListed 2000
HBIO share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered officeHolliston
GSTIN—
Email—
Websitehttp://www.harvardbioscience.com
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of Harvard Bioscience
Competitors10identified
Countries1most in United States
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | lilly.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | jjmt.com.tw | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pg.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | merck.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | amgen.com | 1983 | United States | |
| Part of Gilead Sciences. | gilead.com | 1992 | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | abbott.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pfizer.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | bms.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | marriott.com.cn | — | United States |
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Group companies
Business activities and related parties
life sciences
Filings
No filings on record yet.